A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Completed
- Conditions
- Female ContraceptionContraception
- Interventions
- Drug: Transdermal Contraceptive SystemDrug: Norgestimate-containing oral contraceptives with EE
- First Posted Date
- 2006-09-19
- Last Posted Date
- 2016-07-19
- Target Recruit Count
- 423
- Registration Number
- NCT00377988
A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety
Phase 3
Terminated
- Conditions
- Arthroplasty
- Interventions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2014-04-21
- Target Recruit Count
- 367
- Registration Number
- NCT00364533
A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
Phase 3
Completed
- Conditions
- OsteoarthritisPain Intensity AssessmentArthralgiaSciaticaLow Back Pain
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2011-06-09
- Target Recruit Count
- 877
- Registration Number
- NCT00364546
A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With Placebo Followed by a Voluntary Open Label Extension for Safety.
Phase 3
Completed
- Conditions
- BunionPain AssessmentArthralgiaHallux ValgusTapentadol
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2011-06-09
- Target Recruit Count
- 602
- Registration Number
- NCT00364247
A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain
Phase 3
Completed
- Conditions
- Osteoarthritis, HipLower Back PainOsteoarthritis, KneePain
- Interventions
- First Posted Date
- 2006-08-08
- Last Posted Date
- 2014-04-29
- Target Recruit Count
- 1123
- Registration Number
- NCT00361504
A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery
Phase 3
Completed
- Conditions
- OsteoarthritisPain AssessmentArthralgia
- First Posted Date
- 2006-08-08
- Last Posted Date
- 2011-06-15
- Target Recruit Count
- 669
- Registration Number
- NCT00361582
A Phase 2 Study of Farnesyl Transferase Inhibitor (R115777, Tipifarnib) in Patients With Refractory or Relapsed Acute Myeloid Leukemia.
Phase 2
Completed
- Conditions
- Leukemia, Nonlymphocytic, Acute
- First Posted Date
- 2006-07-20
- Last Posted Date
- 2011-02-01
- Target Recruit Count
- 252
- Registration Number
- NCT00354146
The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery
Phase 4
Terminated
- Conditions
- Hemostasis, Surgical
- Interventions
- Drug: Standard of Care
- First Posted Date
- 2006-07-10
- Last Posted Date
- 2013-07-22
- Target Recruit Count
- 37
- Registration Number
- NCT00350519
Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
Phase 3
Completed
- Conditions
- Multiple MyelomaMyelomaM-ProteinMyeloma Proteins
- First Posted Date
- 2006-06-26
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 198
- Registration Number
- NCT00344422
A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy.
Phase 3
Completed
- Conditions
- ChemotherapyAnemiaCancer
- First Posted Date
- 2006-06-21
- Last Posted Date
- 2011-06-10
- Target Recruit Count
- 69
- Registration Number
- NCT00341055
© Copyright 2025. All Rights Reserved by MedPath